BackFulcrum Therapeutics Overview
Fulcrum Therapeutics Inc

Fulcrum Therapeutics Target Price

Analysts' 12-month price predictions for FULC.

Get informed when a big investor buys or sells

+ Follow

Share Price

$3.59

Average Target Price

$3.600.3% upside

5 analysts in the last 4 months

High: $4 | Low: $3

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-06-02H.C. WainwrightAndrew Fein$316.4% downsideOpen
2026-06-02Jefferies$411.4% upsideOpen
2026-06-02Leerink Partners$411.4% upsideOpen
2026-06-02Truist FinancialGregory Renza$411.4% upsideOpen
2026-06-02Piper Sandler$316.4% downsideOpen
2026-02-24Truist FinancialGregory Renza$17373.5% upsideOpen
2025-12-11Truist Financial$18401.4% upsideOpen
2025-12-08Stifel Nicolaus$25596.4% upsideOpen
2025-12-08Cantor FitzgeraldKristen Kluska$24568.5% upsideOpen
2025-12-08RBC Capital$10178.6% upsideOpen
2025-12-08Piper Sandler$23540.7% upsideOpen
2025-12-08H.C. Wainwright$25596.4% upsideOpen
2025-11-24Truist Financial$14290% upsideOpen
2025-11-24H.C. WainwrightAndrew Fein$18401.4% upsideOpen
2025-10-30Piper Sandler$16345.7% upsideOpen
2025-10-21Leerink Partners$20457.1% upsideOpen
2025-07-29H.C. Wainwright$12234.3% upsideOpen
2025-05-29Piper SandlerEdward Tenthoff$9150.7% upsideOpen
2025-05-23Leerink PartnersJoseph Schwartz$12234.3% upsideOpen
2024-09-13H.C. WainwrightAndrew Fein$411.4% upsideOpen
2024-09-12RBC CapitalGregory Renza$411.4% upsideOpen
2024-09-12Stifel NicolausDae Gon Ha downgraded Fulcrum Therapeutics$316.4% downsideOpen
2024-09-12Bank of America SecuritiesTazeen Ahmad$244.3% downsideOpen
2024-09-09Bank of America SecuritiesTazeen Ahmad$10178.6% upsideOpen
2024-09-03RBC CapitalGregory Renza$15317.8% upsideOpen
2024-05-20Cantor FitzgeraldKristen Kluska$23540.7% upsideOpen
2024-05-13Goldman SachsCorinne Jenkins$15317.8% upsideOpen
2024-05-13Stifel NicolausDae Gon Ha$22512.8% upsideOpen
2024-03-13RBC CapitalGregory Renza$14290% upsideOpen
2022-11-15Goldman Sachs$11206.4% upsideOpen
2022-11-08Piper SandlerEdward Tenthoff$18401.4% upsideOpen